Furthermore, we showed that CD74 is involved in the uptake of rTIMP‐1 by the triple negative breast cancer cell line, MDA‐MB‐231, and that this binding effects Akt signaling, which can lead to various cell responses. This evidence concerns the gene CD74 and triple-negative breast carcinoma.